{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T02:46:23Z","timestamp":1787021183154,"version":"build-2736575974"},"reference-count":17,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2013,8,30]],"date-time":"2013-08-30T00:00:00Z","timestamp":1377820800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["AAPS PharmSciTech"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1208\/s12249-013-0015-5","type":"journal-article","created":{"date-parts":[[2013,8,29]],"date-time":"2013-08-29T15:20:17Z","timestamp":1377789617000},"page":"1333-1340","source":"Crossref","is-referenced-by-count":15,"title":["Stability of Benzocaine Formulated in Commercial Oral Disintegrating Tablet Platforms"],"prefix":"10.1208","volume":"14","author":[{"given":"Melanie","family":"K\u00f6llmer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Popescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashanth","family":"Manda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leon","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Gemeinhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2013,8,30]]},"reference":[{"issue":"6","key":"15_CR1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1615\/CritRevTherDrugCarrierSyst.v21.i6.10","volume":"21","author":"YR Fu","year":"2004","unstructured":"Fu YR, Yang SC, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Crit Rev Ther Drug. 2004;21(6):433\u201375.","journal-title":"Crit Rev Ther Drug"},{"issue":"5","key":"15_CR2","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1517\/17425247.2011.566553","volume":"8","author":"D Douroumis","year":"2011","unstructured":"Douroumis D. Orally disintegrating dosage forms and taste-masking technologies; 2010. Expert Opin Drug Deliv. 2011;8(5):665\u201375.","journal-title":"Expert Opin Drug Deliv"},{"key":"15_CR3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2147\/PPA.S27344","volume":"6","author":"W Montgomery","year":"2012","unstructured":"Montgomery W, Treuer T, Karagianis J, Ascher-Svanum H, Harrison G. Orally disintegrating olanzapine review: effectiveness, patient preference, adherence, and other properties. Patient Prefer Adherence. 2012;6:109\u201325.","journal-title":"Patient Prefer Adherence"},{"issue":"11","key":"15_CR4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s12325-010-0073-y","volume":"27","author":"V Navarro","year":"2010","unstructured":"Navarro V. Improving medication compliance in patients with depression: use of orodispersible tablets. Adv Ther. 2010;27(11):785\u201395.","journal-title":"Adv Ther"},{"key":"15_CR5","unstructured":"US FDA. Guidance for industry orally disintegrating tablets. Silver Spring, MD: Office of Pharmaceutical Science in the Center for Drug Evaluation and Research (CDER) at the Food and Drug Administration; 2008."},{"issue":"4","key":"15_CR6","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1208\/s12249-011-9677-z","volume":"12","author":"Y Wu","year":"2011","unstructured":"Wu Y, Levons J, Narang AS, Raghavan K, Rao VM. Reactive impurities in excipients: profiling, identification and mitigation of drug\u2013excipient incompatibility. AAPS PharmSciTech. 2011;12(4):1248\u201363.","journal-title":"AAPS PharmSciTech"},{"key":"15_CR7","unstructured":"Prasad A, Langley N. The effect of secondary oxidation impurities in PVP on API stability. Tarrytown, NY: BASF Corporation"},{"key":"15_CR8","unstructured":"ICH. Stability testing of new drug substances and products Q1A(R2). Step 4: International Conference on the Harmonisation of Technical Requirements for Registration of Pharmaceutical for Human Use; 2003."},{"issue":"5","key":"15_CR9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/j.jpba.2005.02.037","volume":"38","author":"SK Branch","year":"2005","unstructured":"Branch SK. Guidelines from the International Conference on Harmonisation (ICH). J Pharm Biomed Anal. 2005;38(5):798\u2013805.","journal-title":"J Pharm Biomed Anal"},{"key":"15_CR10","unstructured":"Rumbelow S, Brown JC, editors. Investigations into drug stability using LC-MS-MS data and statistical data processing. 57th American Society of Mass Spectrometry, Philadelphia, USA; 2009."},{"issue":"12","key":"15_CR11","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1002\/jps.2600691208","volume":"69","author":"PK Narang","year":"1980","unstructured":"Narang PK, Bird G, Crouthamel WG. High-performance liquid chromatographic assay for benzocaine and p-aminobenzoic acid including preliminary stability data. J Pharm Sci. 1980;69(12):1384\u20137.","journal-title":"J Pharm Sci"},{"issue":"3","key":"15_CR12","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.jpba.2005.12.033","volume":"41","author":"MA Barrio del","year":"2006","unstructured":"del Barrio MA, Hu J, Zhou P, Cauchon N. Simultaneous determination of formic acid and formaldehyde in pharmaceutical excipients using headspace GC\/MS. J Pharm Biomed Anal. 2006;41(3):738\u201343.","journal-title":"J Pharm Biomed Anal"},{"issue":"4","key":"15_CR13","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1002\/jps.21119","volume":"97","author":"KC Waterman","year":"2008","unstructured":"Waterman KC, Arikpo WB, Fergione MB, Graul TW, Johnson BA, Macdonald BC, et al. N-Methylation and N-formylation of a secondary amine drug (varenicline) in an osmotic tablet. J Pharm Sci. 2008;97(4):1499\u2013507.","journal-title":"J Pharm Sci"},{"issue":"5 Supplement","key":"15_CR14","first-page":"VII","volume":"28","author":"PJ Crowley","year":"2010","unstructured":"Crowley PJ, Martini LG. Effects of excipients on the stability of medicinal products. Chem Today. 2010;28(5 Supplement):VII\u2013XIII.","journal-title":"Chem Today"},{"issue":"11","key":"15_CR15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/jps.2600671135","volume":"67","author":"HM El-Banna","year":"1978","unstructured":"El-Banna HM, Daabis NA, El-Fattah SA. Aspirin stability in solid dispersion binary systems. J Pharm Sci. 1978;67(11):1631\u20133.","journal-title":"J Pharm Sci"},{"issue":"1","key":"15_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1021\/js9702067","volume":"87","author":"DD Wirth","year":"1998","unstructured":"Wirth DD, Baertschi SW, Johnson RA, Maple SR, Miller MS, Hallenbeck DK, et al. Maillard reaction of lactose and fluoxetine hydrochloride, a secondary amine. J Pharm Sci. 1998;87(1):31\u20139.","journal-title":"J Pharm Sci"},{"key":"15_CR17","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.3109\/03639049409041966","volume":"20","author":"RC George","year":"1994","unstructured":"George RC, Barbuch RJ, Huber EW, Regg BT. Investigation into the yellowing on aging of Sabril\u00ae tablet cores. Drug Dev Ind Pharm. 1994;20:3023\u201332.","journal-title":"Drug Dev Ind Pharm"}],"container-title":["AAPS PharmSciTech"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-013-0015-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1208\/s12249-013-0015-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1208\/s12249-013-0015-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T23:48:23Z","timestamp":1559605703000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1208\/s12249-013-0015-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,8,30]]},"references-count":17,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["15"],"URL":"https:\/\/doi.org\/10.1208\/s12249-013-0015-5","relation":{},"ISSN":["1530-9932"],"issn-type":[{"value":"1530-9932","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,8,30]]}}}